[go: up one dir, main page]

WO2010049011A3 - Wirkstoffkombination zur behandlung reifer haut ii - Google Patents

Wirkstoffkombination zur behandlung reifer haut ii Download PDF

Info

Publication number
WO2010049011A3
WO2010049011A3 PCT/EP2008/067766 EP2008067766W WO2010049011A3 WO 2010049011 A3 WO2010049011 A3 WO 2010049011A3 EP 2008067766 W EP2008067766 W EP 2008067766W WO 2010049011 A3 WO2010049011 A3 WO 2010049011A3
Authority
WO
WIPO (PCT)
Prior art keywords
dalton
skin
hyaluronic acid
active
silanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/067766
Other languages
English (en)
French (fr)
Other versions
WO2010049011A2 (de
Inventor
Iris Marina Stadler
Annika Bähren
Alexandra Struwe
Marianne Waldmann-Laue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to RU2011121874/15A priority Critical patent/RU2011121874A/ru
Priority to EP08875470A priority patent/EP2451434A2/de
Publication of WO2010049011A2 publication Critical patent/WO2010049011A2/de
Anticipated expiration legal-status Critical
Publication of WO2010049011A3 publication Critical patent/WO2010049011A3/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die Erfindung betrifft topische kosmetische oder dermatologische Zusammensetzungen zur Behandlung reifer oder intrinsisch oder extrinsisch gealterter Haut, insbesondere zur Antifaltenbehandlung, die in einem geeigneten kosmetischen oder dermatologischen Träger eine Kombination von mindestens ein Sojaproteinhydrolysat mit einem mittleren Molekulargewicht im Bereich von 600 - 1000 Dalton, bevorzugt 800 Dalton, mindestens einen hydrophilen Extrakt aus Ambrette-Samen, mindestens einen Wirkstoff, ausgewählt aus Hyaluronsäure, den Silanolethern, den Silanolestern und den Salzen der Hyaluronsäure, und mindestens ein Di-, Tri-, Tetra-, Penta- oder Hexapeptid, das N-acyliert und/oder verestert sein und/oder als physiologisch verträgliches Salz vorliegen kann und das in der Haut die Freisetzung von Wachstumsfaktoren wie z.B. TGF- und nachfolgend die Collagen- und/oder Fibronectinsynthese stimuliert, enthalten.
PCT/EP2008/067766 2008-10-31 2008-12-17 Wirkstoffkombination zur behandlung reifer haut ii Ceased WO2010049011A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2011121874/15A RU2011121874A (ru) 2008-10-31 2008-12-17 Комбинация биологически активных веществ для обработки зрелой кожи ii
EP08875470A EP2451434A2 (de) 2008-10-31 2008-12-17 Wirkstoffkombination zur behandlung reifer haut ii

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008054117.6 2008-10-31
DE102008054117A DE102008054117A1 (de) 2008-10-31 2008-10-31 Wirkstoffkombination zur Behandlung reifer Haut II

Publications (2)

Publication Number Publication Date
WO2010049011A2 WO2010049011A2 (de) 2010-05-06
WO2010049011A3 true WO2010049011A3 (de) 2012-06-07

Family

ID=42062976

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/067766 Ceased WO2010049011A2 (de) 2008-10-31 2008-12-17 Wirkstoffkombination zur behandlung reifer haut ii

Country Status (4)

Country Link
EP (1) EP2451434A2 (de)
DE (1) DE102008054117A1 (de)
RU (1) RU2011121874A (de)
WO (1) WO2010049011A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016520069A (ja) * 2013-05-10 2016-07-11 サザン・リサーチ・インスティテュート ＴＧＦ‐β活性阻害を介した疾患の治療のための化合物、組成物及び方法
WO2017013172A1 (en) * 2015-07-23 2017-01-26 Stichting Katholieke Universiteit Novel inhibitors of p-glycoprotein
CA3013459C (en) 2016-02-04 2020-12-29 ALASTIN Skincare, Inc. Topical compositions comprising tripeptide-1 and hexapeptide-12
CN111182914A (zh) 2017-08-03 2020-05-19 阿拉斯廷护肤公司 用于改善皮肤松弛和身体轮廓的组合物和方法
WO2019060357A1 (en) * 2017-09-21 2019-03-28 Muhammed Majeed PROCESS FOR THE PREPARATION OF TRIPEPTIDE CONTAINING OLEANOLIC ACID AND ASSOCIATED THERAPEUTIC APPLICATIONS
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
DE102019218242A1 (de) * 2019-11-26 2021-05-27 Beiersdorf Ag Wirkstoffkombinationen aus Ubichinol und Hyaluronsäure und kosmetische oder dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
CN111759748B (zh) * 2020-08-14 2023-04-11 广州市乾相生物科技有限公司 一种抗衰老肽类组合物及其应用
CN116327636B (zh) * 2023-03-06 2024-06-25 山东福瑞达生物股份有限公司 一种保湿修护组合物及其应用、制备方法
EP4647063A1 (de) * 2024-05-07 2025-11-12 Etichub S.r.l. Kosmetisches verfahren zur optimierung ästhetischer parameter der haut und hautanhangsgebilde

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1640041A2 (de) * 2004-09-24 2006-03-29 Henkel Kommanditgesellschaft auf Aktien Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer oder lichtgeschädigter Haut
WO2006080768A1 (en) * 2005-01-31 2006-08-03 Amorepacific Corporation Anti-aging cosmetic composition
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
EP1790330A2 (de) * 2005-10-14 2007-05-30 Henkel Kommanditgesellschaft auf Aktien Kosmetische und dermatologische Zusammensetzungen mit Oligopeptiden und Apfelextrakt
EP1815843A2 (de) * 2005-12-29 2007-08-08 Henkel KGaA Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
WO2008029064A2 (fr) * 2006-09-06 2008-03-13 Thorel Jean-Noel Utilisation topique d'un extrait peptidique de soja et/ou de ble comme agent photoprotecteur
DE102007024679A1 (de) * 2006-10-17 2008-07-10 Engelhard Lyon S.A. Verwendung von kosmetisch aktiven Wirkstoffen zum Schützen von FGF-2
WO2009121422A1 (en) * 2008-04-02 2009-10-08 Basf Beauty Care Solutions France Sas Active ingredient that stimulates the proliferation and/or activity of fibroblasts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163246A1 (de) 2001-12-21 2003-07-10 Henkel Kgaa Neue Verwendung von Apfelkernextrakten in kosmetischen oder pharmazeutischen Zusammensetzung

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
EP1640041A2 (de) * 2004-09-24 2006-03-29 Henkel Kommanditgesellschaft auf Aktien Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer oder lichtgeschädigter Haut
WO2006080768A1 (en) * 2005-01-31 2006-08-03 Amorepacific Corporation Anti-aging cosmetic composition
EP1790330A2 (de) * 2005-10-14 2007-05-30 Henkel Kommanditgesellschaft auf Aktien Kosmetische und dermatologische Zusammensetzungen mit Oligopeptiden und Apfelextrakt
EP1815843A2 (de) * 2005-12-29 2007-08-08 Henkel KGaA Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
WO2008029064A2 (fr) * 2006-09-06 2008-03-13 Thorel Jean-Noel Utilisation topique d'un extrait peptidique de soja et/ou de ble comme agent photoprotecteur
DE102007024679A1 (de) * 2006-10-17 2008-07-10 Engelhard Lyon S.A. Verwendung von kosmetisch aktiven Wirkstoffen zum Schützen von FGF-2
WO2009121422A1 (en) * 2008-04-02 2009-10-08 Basf Beauty Care Solutions France Sas Active ingredient that stimulates the proliferation and/or activity of fibroblasts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Pentapharm Syn-Coll", 4 November 2008 (2008-11-04), pages 1 - 4, XP002502708, Retrieved from the Internet <URL:http://web.archive.org/web/20070306175636/http://www.ingredientstodie for.com/files/DATA_Syn-Coll.pdf> [retrieved on 20081104] *

Also Published As

Publication number Publication date
RU2011121874A (ru) 2012-12-10
EP2451434A2 (de) 2012-05-16
DE102008054117A1 (de) 2010-05-06
WO2010049011A2 (de) 2010-05-06

Similar Documents

Publication Publication Date Title
WO2010049011A3 (de) Wirkstoffkombination zur behandlung reifer haut ii
KR101686399B1 (ko) 항노화용 화장료 조성물
US20070207180A1 (en) Synthetic polypeptide-containing bioapplicable material and film-forming material
CN111182914A (zh) 用于改善皮肤松弛和身体轮廓的组合物和方法
US20130295122A1 (en) Elastin digest compositions and methods utilizing same
KR101978095B1 (ko) 벌꿀과 펩티드의 조합을 포함하는 화장품 또는 피부병치료 조성물
WO2009136291A3 (en) Cellular extracts
JP6430109B2 (ja) 外用組成物
EP2656832A3 (de) Verwaltung von Zellen und Zellextrakten zur Verjüngung
AU2008243084B2 (en) Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions
CN109152727B (zh) 可可豆的肽和糖水解产物、含有其的化妆品组合物以及该化妆品组合物的化妆品用途
ES2769268T3 (es) Extracto sinérgico de Palmaria palmata
WO2010049457A3 (de) Wirkstoffkombination zur behandlung reifer haut i
US20200354431A1 (en) Mutable collagenous tissue from echinoderms
GB2543822A (en) Skin care composition and method thereof
JP2016501866A5 (de)
US20230148647A1 (en) Composition for promoting biosynthesis of elastin and collagen in connective tissue
WO2009138801A2 (en) Cosmetic formulation
JP6153469B2 (ja) ダイズタンパク質の加水分解物を含有する組成物
WO2010146078A3 (en) Novel uses of hydroxyproline compositions
Bojarska Amino acids and short peptides as anti-aging “Superfood”
WO2011051457A3 (en) Purified emd protein composition
KR20220030151A (ko) 연결 조직 중 엘라스틴 및 콜라겐 생합성 증진용 조성물
WO2010119997A1 (ko) 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도
US20160243021A1 (en) Collagen-Boosting Compositions And Methods

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008875470

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008875470

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011121874

Country of ref document: RU